INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 17 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $49,000 | – | 11,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,752 | $7,000 | 0.00% |
| Renaissance Technologies | 27,725 | $119,000 | 0.00% |
| ROYAL BANK OF CANADA | 70 | $0 | 0.00% |
| VANGUARD GROUP INC | 16,946 | $73,000 | 0.00% |
| UBS Group AG | 5,540 | $24,000 | 0.00% |
| IFP Advisors, Inc | 1 | $1,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11,521 | $49,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 1 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 7 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 9 | $0 | 0.00% |